@abcnews: Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients who had melanoma - a dangerous type of skin cancer. The individualized vaccine, when paired with the existing immunotherapy, Keytruda, is the first and only combination regimen that demonstrated success in potentially extending melanoma patients' lifespans. The complete data set has not been made public or submitted to regulators for approval yet, but the initial results appear promising.

Vanislandboy :

Too bad Covid destroyed people’s faith in vaccines.

Zelda Stark :

vaccines save lives.

Standupforscience :

This is what happens when we fund science!!! Yet the Trump admin is decimating American science. We are fighting back ✊🧪

ام محمد 🤍🩷 :

Because we believed in vaccines!!

badger.com :

a promise for the dead

._Pr3ttyrichgeek_.💌❣️.. :

Thanks goodness

puppybreath :

He sounds too much like ai

𝓘 𝓵𝓸𝓿𝓮 𝓪𝓼𝓽𝓻𝓸𝓷𝓸𝓶𝔂 :

uhh is that true

Bababooey :

Hi

🌍 :

wow

Isa88 :

FrontStepTellings :

uuughhh another vaccine

morganamajik :

That’s hilarious come on too much money would be lost this is bullshit

သာပေါင်းလေး :

🥰🥰🥰